Latest DEF 14A proxy statements

BlackRock Municipal Income Quality Trust shareholders are urged to vote on a fund combination expected to boost after-tax yield and reduce expenses.

Metsera's Board unanimously recommends stockholders approve the merger with Pfizer for $47.50 cash plus a contingent value right up to $22.50 per share, valuing the deal at a 110% premium.

BlackRock New York Municipal Income Trust urges shareholders to vote on a proposed fund combination expected to increase after-tax yield and reduce expenses.

Priority Income Fund, Inc. has filed a definitive proxy statement with the SEC, signaling upcoming shareholder votes.

BlackRock Investment Quality Municipal Trust, Inc. (BKN) urges shareholders to vote on a proposed fund combination, with the special meeting adjourned to November 20, 2025, citing expected expense reductions and other benefits.

Prospect Capital Corporation filed definitive additional proxy materials with the SEC under Section 14(a) of the Securities Exchange Act of 1934.

BlackRock MuniYield Quality Fund II, Inc. (MQT) shareholders are urged to vote on a proposed six-fund combination, with the special meeting adjourned to November 20, 2025.

BlackRock MuniYield Michigan Quality Fund, Inc. (MIY) adjourned its special shareholder meeting to November 20, 2025, to allow more time for voting on a proposed fund combination expected to increase after-tax yield and reduce expenses.

BlackRock MuniYield Fund (MYD) seeks shareholder approval for a proposed six-fund combination, projecting expense ratio declines, with the vote adjourned to November 20, 2025.

eGain Corporation announces its Annual Meeting of Stockholders on December 9, 2025, to elect directors, approve executive compensation, and ratify its independent auditor.

Xcel Brands, Inc. announced its 2025 Annual Meeting of Stockholders to be held on December 3, 2025, where key proposals include the election of five directors, an increase in shares for its equity incentive plan, and the ratification of a new independent accounting firm.

Gyrodyne, LLC announces its 2025 Annual Meeting to elect a director, approve executive compensation, and ratify auditors, following a resolved proxy contest.

Beyond Meat calls a Special Meeting to approve critical proposals, including a massive share increase and potential reverse stock split, following a significant debt exchange that caused substantial shareholder dilution.

Destiny Tech100 Inc. announced its annual shareholder meeting for November 28, 2025, to elect new directors and ratify KPMG as its auditor.

Great Elm Group, Inc. announces its 2025 Annual Stockholders Meeting to vote on director elections, auditor ratification, executive compensation, and a new long-term incentive plan.

Envoy Medical, Inc. calls a Special Meeting to approve the issuance of warrants and underlying Class A Common Stock to comply with Nasdaq listing rules following a recent securities offering.

BigBear.ai Holdings, Inc. will hold a Special Meeting on December 1, 2025, to vote on increasing its authorized common stock from 500 million to 1 billion shares.

LAVA Therapeutics and XOMA Royalty amend their share purchase agreement, reducing the cash per share to $1.04 and adjusting contingent value rights, while extending the tender offer and reconvening the EGM.

Kentucky First Federal Bancorp announces its 2025 Annual Meeting of Stockholders to vote on director elections, auditor ratification, and executive compensation, while disclosing key governance updates and financial performance.

Cartesian Growth Corporation II, a SPAC, has entered into a non-binding Letter of Framework with PLXSUR Limited for a potential business combination, outlining key terms and a shared vision.

BigBear.ai Holdings, Inc. will hold a Special Meeting on December 1, 2025, to seek stockholder approval to double its authorized common stock to 1 billion shares.

Hillenbrand, Inc. has entered into a definitive merger agreement to be acquired by affiliates of Lone Star Funds for $32.00 per share in cash.

STAAR Surgical Company reiterates that it has received no acquisition proposals other than from Alcon, refuting claims by Broadwood Partners ahead of a crucial stockholder vote.

ATAI Life Sciences and Beckley Psytech announced that the U.S. FDA granted Breakthrough Therapy designation to BPL-003 for treatment-resistant depression, signaling potential for expedited development.

TrueCar, Inc. announced a proposed acquisition by Fair Holdings, Inc., a company led by TrueCar founder Scott Painter and backed by Alpha Auto 2, LLC.

Nukkleus Inc. announced its 2025 Annual Meeting of Stockholders to vote on director elections, auditor ratification, and a new equity incentive plan, alongside details of a significant acquisition of Star, a defense and technology company.

Algorhythm Holdings, Inc. proposes a reverse stock split, reincorporation to Nevada, and approval for dilutive pre-paid financing shares amidst significant financial losses and declining stockholder returns.

Workhorse Group Inc. is urging shareholders to vote for its all-stock merger with Motiv Power Systems, Inc. to create a leading medium-duty electric truck OEM and avoid severe liquidity issues.

Workhorse Group Inc. is soliciting shareholder votes for its upcoming Annual Meeting to approve the merger with Motiv Power Systems, Inc.

Workhorse Group Inc. reminds shareholders to vote FOR the proposed all-stock merger with Motiv Electric Trucks and all related proposals at the upcoming November 12, 2025 Annual Meeting to create a leading North American medium-duty electric truck OEM.